WO2013117910A1 - Lutte contre les pathogènes et nuisibles - Google Patents

Lutte contre les pathogènes et nuisibles Download PDF

Info

Publication number
WO2013117910A1
WO2013117910A1 PCT/GB2013/050228 GB2013050228W WO2013117910A1 WO 2013117910 A1 WO2013117910 A1 WO 2013117910A1 GB 2013050228 W GB2013050228 W GB 2013050228W WO 2013117910 A1 WO2013117910 A1 WO 2013117910A1
Authority
WO
WIPO (PCT)
Prior art keywords
insect
bacterial cell
cell according
gene
gut
Prior art date
Application number
PCT/GB2013/050228
Other languages
English (en)
Inventor
Paul Dyson
Miranda WHITTEN
Original Assignee
Swansea University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Swansea University filed Critical Swansea University
Priority to GB1415502.2A priority Critical patent/GB2513811A/en
Publication of WO2013117910A1 publication Critical patent/WO2013117910A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/60—Isolated nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111—General methods applicable to biologically active non-coding nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8218—Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8286—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for insect resistance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/30—Special therapeutic applications
    • C12N2320/32—Special delivery means, e.g. tissue-specific
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2330/00—Production
    • C12N2330/50—Biochemical production, i.e. in a transformed host cell
    • C12N2330/51—Specially adapted vectors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
    • Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants

Definitions

  • the invention relates to a genetically transformed or transfected bacterial cell of a gut symbiont of an insect vector wherein said cell is transformed to express double- stranded RNA (dsRNA) active against at least one selected insect gene; an insect including said transformed bacterial cell and a method of pest control and/or pathogen transmission control employing the use of said bacterial cell and/or said insect.
  • dsRNA double- stranded RNA
  • Invertebrates and other pests are common vectors for pathogenic organisms, typically micro-organisms, that are responsible for a variety of human diseases.
  • Arthropods including insects, account for over 80 percent of all known animal species, and they are one of the most important disease vectors. Insects are commonly the cause for spreading a range of different bacterial, viral, and protozoan pathogens associated with different diseases. Transmission of a communicable disease from an infected host insect or group to a conspecific individual or group commonly occurs either via their bite, such as in the case of haematophagous insects, or via contaminated faeces. For example, one of the most commonly known insect-borne diseases is that of malaria which is transmitted via the Anopheles genus of mosquito.
  • mosquito-borne diseases include yellow fever, dengue fever, and encephalitis, and are estimated to transmit disease to more than 700 million people annually in Africa, South America, Central America, Mexico and much of Asia. Globally, 216 million cases of Malaria occur annually and it is responsible for the death of over 655,000 people, with it estimated that 6.5% of the world's population are at risk of infection. Additionally, Dengue fever is the world's fastest growing vector-borne disease. Similarly, flies constitute a large group of vectors of pathogenic micro-organisms, such as the Sandfly species and leishmaniasis, and the tsetse fly and protozoan trypanosomes.
  • T. cruzi is commonly transmitted to humans and other mammals by an insect vector, the blood-sucking insects of the subfamily Triatominae (family Reduviidae), most commonly species belong to the Triatoma, Rhodnius, and Panstrongylus genera.
  • the disease may also be spread through blood transfusion and organ transplantation, ingestion of food contaminated with parasites, and from a mother to her fetus.
  • Antiparasitic treatments appear to delay or prevent the development of Chagas disease symptoms during the chronic phase of the disease, but 20-40% of chronically infected individuals will still eventually develop life-threatening heart and digestive system disorders.
  • Chagas disease is contracted primarily in the Americas, particularly in poor, rural areas of Mexico, Central America, and South America. It is estimated that as many as 8 to 1 1 million people in Mexico, Central America, and South America have Chagas disease. Large-scale population movements from rural to urban areas of Latin America and to other regions of the world have increased the geographic distribution of Chagas disease, and cases have been noted in many countries, particularly in Europe. Control strategies have mostly focused on eliminating the triatomine insect vector and preventing transmission from other sources.
  • RNA interference RNA interference
  • RNAi is a form of post-transcriptional gene silencing wherein a specific mRNA of a particular gene is destroyed or blocked, preventing translation and formation of an active gene product. RNAi occurs naturally within living cells to modulate gene activity, and is also important in defence against parasites and viral infection. For example, when a cell is injected with RNA in a double-stranded (ds) form, a protein called Dicer (or RNase III) cleaves the dsRNA molecules into short fragments of RNA (20-25 nucleotides), termed short interfering RNA (siRNA) due to their ability to interfere with the expression of a specific gene.
  • ds double-stranded
  • siRNA short interfering RNA
  • siRNA molecules are unwound into single stranded (ss) RNA, whereupon the so-called guide strand is incorporated into the RNA-induced silencing complex (RISC). Often, this guide strand will base pair with a complimentary sequence of mRNA in the cell inducing its cleavage by the catalytic component of the RISC complex. The mRNA is not translated and no functional protein is produced, and therefore the effects of the gene encoding the specific mRNA are 'silenced'. This process is termed cell- autonomous RNAi, wherein gene silencing is limited to the cell in which the dsRNA is introduced.
  • RISC RNA-induced silencing complex
  • environmental and systemic RNAi are the two forms of non-cell autonomous RNAi, wherein the interfering effect takes place in cells/tissues different from where the dsRNA was introduced/produced.
  • the dsRNA is either taken up into multiple cells (environmental RNAi such as in viral infections), or the silencing signal is transported from the cell in which the dsRNA is applied or expressed to other cells where the effect is observed (systemic RNAi).
  • dsRNA or siRNA molecules
  • insect species selected for genome sequencing represent species that either inflict suffering (e.g. the mosquito Anopheles gambiae), or provide spectacular models for animal development (e.g. the fruitfly Drosophila melanogaster). Indeed the dsRNA technique was rapidly adapted for use in the Anopheles mosquito.
  • RNAi in invertebrates is an established technology, wherein dsRNA is delivered most commonly by injection.
  • this process often has high mortality rates due to injection trauma and anaesthesia, and also requires high sample numbers.
  • Large insects also require expensive quantities of dsRNA to be synthesised.
  • this results in cell-autonomous gene silencing achieving transient RNAi effects and, therefore, is not applicable for control of insect pests in the field.
  • the latter has been the only means of delivery of dsRNA to blood-feeding insects such as malarial Anopheles species.
  • RNAi non-cell autonomous RNAi
  • a biological source such as genetically modified bacteria or plant material
  • Huvenne & Smagghe, 2010 This therefore begins with uptake of dsRNA environmentally into the gut lumen of the insect, where it is then spread to tissues elsewhere (systemic RNAi).
  • systemic RNAi systemic RNAi
  • Achieving RNAi depends on a reliable method to deliver, or uptake, a dsRNA copy of part of a target gene to the insect. For some insect species this has been achieved by including in their food live or dead E. coli cells expressing dsRNA.
  • RNAi can be introduced by ingestion of: naked dsRNA, food contaminated with E. coli expressing dsRNA e.g. by spraying with transformed bacteria, or genetically modified plant material expressing dsRNA.
  • WO201 1017137 A2 teaches a method whereby a food bait of the insect is contaminated with genetically modified bacteria expressing dsRNA and the bait is returned to the colony to be fed on by the insects.
  • WO201 1025860A1 teaches the use of RNAi against plant-feeding insects, wherein bacteria that infect specific plants are genetically modified to express specific dsRNA.
  • WO201 1036536A2 teaches specific RNAi gene targets which are silenced by the delivery of dsRNA by spraying dead bacteria onto crop plants.
  • RNAi methods must evolve to accommodate a wider variety of species.
  • RNAi delivery technique that relies on the in vivo synthesis of dsRNA by transgenic symbiotic gut bacteria that naturally reside in the insect host.
  • Each insect species has its own specific gut microflora.
  • the genetically modified symbionts therefore become established as a living population in the gut of the insect over the insect life-cycle, dividing within their hosts actively producing RNA, and can consequently mediate RNAi over prolonged periods.
  • the dsRNA is directed against genes of the insect, leading to a knockdown effect that reveals the role of the target gene. It can also be used to target genes that disable the host (e.g. those required for survival or reproduction) in pest control. Further, we have demonstrated horizontal transmission of the transformed bacteria by coprophagy in insects, potentially representing an important mode of spread amongst the insect population.
  • a genetically transformed or transfected bacterial cell wherein said bacteria is a gut symbiont of an insect; characterised in that said bacterial cell is transformed to express dsRNA against at least one selected target gene of the insect.
  • insect is reference to an organism belonging to the class Insecta.
  • said insect belongs to the order, although not limited to, Anoplura, Blattodea, Coloeoptera, Dermaptera, Dictyoptera, Diptera, Embioptera, Ephemeroptera, Grylloblattidae, Hemiptera, Hymenoptera, Isoptera, Phthiraptera, Plecoptera, Psocoptera, Siphonaptera, Thysanura, Strepsiptera, Thysanoptera, Trichoptera, or the like.
  • said insect refers to any insect vector that transmits a pathogenic organism known to cause disease in a plant or animal host.
  • said insect vector belongs to the genus Rhodnius. More preferably still, said insect vector is Rhodnius prolixus.
  • said pathogenic organism is to be construed as any micro-organism known to cause a disease in a plant or animal host. This includes, but is not limited to, a virus, bacterium, prion, protozoan or fungus. More preferably, said pathogenic organism is a protozoan. More preferably still, said pathogenic organism belongs to the genus Trypanosoma. Yet more preferably still, said pathogen is Trypanosoma cruzi.
  • said pathogenic microorganism is responsible for causing disease in animals. More preferably, said pathogenic micro-organism is responsible for causing disease in humans, including, but is not limited to, Chikungunya, Japanese encephalitis, La Crosse encephalitis, Phlebotomous fever, St.
  • said insect refers to any insect that acts as a pest to man, animals, or plants, and is thus of significance in a health, husbandry, agricultural, or ecological context.
  • flies and bot flies warble flies and bot flies
  • eye moths Hippoboscidae spp. (e.g. sheep ked), Cimicidae spp. (bed bug), Blattodea (cockroaches)
  • certain species of Coleoptera e.g. woodboring beetles, Darkling beetle, Spider beetle, Cigarette beetle, larder beetle, warehouse beetle, harlequin beetle, rice weevils, grain weevils
  • certain species of Lepidoptera e.g Meal moths, Angoumois grain moth, cocoa moth, wine moth
  • Africanized honey bee Pharaoh ant, or the like.
  • horizontal gut transfer is to be construed as the acquisition of gut flora bacteria by said insect vector or insect from an environmental source, for example, by ingestion.
  • said horizontal gut transfer is achieved by ingestion of faeces from other insects. More ideally still, ingestion of faeces is species specific whereby the parent generation of a species transfers the genetically engineered gut symbiont to an offspring generation.
  • said insect vector or insect can acquire said transformed or transfected bacterial cell from contaminated faeces in the environment, circumventing the need for insect handling and associated mortality.
  • this permits horizontal transfer of dsRNA mediating RNAi throughout at least one insect colony and, typically, many insect colonies.
  • said transformed or transfected bacterial cell can be acquired by other means of transfer, such as, but not limited to, vertical (from adult to offspring e.g. transmission from the maternal parent to the off-spring) transfer or environmental transfer (e.g. via the ingestion of sprayed material).
  • vertical from adult to offspring e.g. transmission from the maternal parent to the off-spring
  • environmental transfer e.g. via the ingestion of sprayed material
  • gut symbiont is reference to a bacteria that successfully colonises the insect gut and, ideally, is found only in that genus or, more ideally, species, of insect at least during, but not limited to, the pathogenic part of the life cycle of the insect vector or at least during, but not limited to, the pest part of the life cycle of the insect.
  • said gut symbiont includes but is not limited to, Rhodococcus corynebacteriodes, Janibacter anophelis, Asaia, Rhodococcus rhodnii, Serratia marcescens, Triatoma infestans, Wigglesworthia glossinidia, Sodalis glossinidius, Rhodococcus opacus, Kluyvera cryocrescens, Lactococcus garviae, Achromobacter xyiosoxidans, Bifidobacterium asteroides, Bifidobacterium coryneforme, Bifidobacterium indicum, Bifidobacterium bombi, Proteus vulgaris, Citrobacter freundii, Serratia liquefaciens or the like.
  • said gut symbiont is unique to a particular insect vector or insect. More preferably still, said gut symbiont belongs to the genus Rhodococcus. Yet more preferably still, said gut symbiont resides in Rhodococcus rhodnii. In this instance, a modified dapA gene promoter is used to generate the dsRNA.
  • said bacterial cell is transformed or genetically modified such that nucleic acid encoding said dsRNA is stably integrated into the host cell genome.
  • This advantageously ensures long-term target gene silencing and ensures spread in insect populations.
  • stable integration is achieved by way of site specific integration, typically following the use of conventional site specific integration sites, and/or homologous recombination.
  • the invention is suitable for use with all invertebrates which have a gut suitable for uptake of dsRNA, and also a symbiotic gut bacteria amenable to genetic manipulation.
  • Reference herein to a gut suitable for the uptake of dsRNA means an insect gut that can uptake dsRNA through feeding and/or digestion. The precise mechanism by which this occurs is yet to be elucidated but active channel transfer and endocytosis have been considered responsible for this process.
  • said dsRNA comprises a strand of RNA that shares 50% complementarity to at least one target gene of said insect vector or insect. It is preferred that said dsRNA comprises a strand of RNA that shares at least 75% complementarity to at least one target gene of said insect vector and, in increasing order of preference, at least 80%, 85%, 90%, 91 %, 92%, 93%, 94%, 95%, 96%, 97%, 98% or 99% complementarity to at least one target gene of said insect vector.
  • said transformed or transfected bacterial cell is also genetically engineered such that it does not produce functional RNA degrading proteins, including but not limited to, RNase I, RNase II, RNase III, RNase D, RNase E, RNase G, RNase P, RNase R, RNase T, RNase Z, RNase PH, RNase BN, RelE, MazF, Kid, PNPase, RhIB, enolase.
  • functional RNA degrading proteins including but not limited to, RNase I, RNase II, RNase III, RNase D, RNase E, RNase G, RNase P, RNase R, RNase T, RNase Z, RNase PH, RNase BN, RelE, MazF, Kid, PNPase, RhIB, enolase.
  • said dsRNA is integrated by homologous recombination into the gene encoding the afore RNA degrading proteins.
  • such genetic recombination will mediate RNAi against the insect vector
  • said target gene of the insect vector or insect is a gene involved in, but not limited to, growth, development, renewal or reproduction of the insect. More preferably, said gene is such that its loss results in reduced growth, renewal or differentiation, a reduction in feeding, or a reduction or loss in the capacity for reproduction. More preferably still, said target gene is such that its loss results in reduced infectivity or pathogenicity of said insect vector, for example, by targeting genes that prevent, or reduce the likelihood, of colonisation of the insect gut by the pathogen.
  • the insect vector's capacity to transmit a pathogenic micro-organism is reduced but said insect vector remains viable such that the ecosystem in which it resides remains relatively stable, or the insect's capacity to act as a pest is reduced but said insect remains viable such that the ecosystem in which it resides remains relatively stable.
  • said target gene is insect-specific, more preferably still said target gene is found only in the insect vector or insect that hosts the genetically transformed gut symbiont.
  • said gene includes, but is not limited to, genes of significance to the immune system such as Defensin, Lysozyne, Transferrin, Prolixin, or alternatively those essential for viability such as the Nitrophorins, salivary Lipocalins, Nitric Oxide Synthase, Vitellogenin, Juvenile Hormone, Odorant binding protein, Rhodnius Heme Binding Protein, or the like. More preferably still said target gene is Vitellogenin or Nitrophorin 1 or Nitrophorin 2.
  • the insect vector or insect acquires the dsRNA genetically transformed or transfected bacterial cell, wherein said bacterial cell is a gut symbiont of the insect vector or insect, from its environment through ingestion. Said bacterial cell thereby establishes itself as a living population in the gut of the insect vector or insect, wherein it divides and actively transcribes the dsRNA which it encodes.
  • this therefore mediates RNAi in the insect vector or insect indefinitely.
  • the dsRNA is targeted against a specific gene of interest of the insect vector or insect, leading to its modulation and more specifically, its down regulation.
  • the insect vector or insect is genetically compromised throughout its life cycle or at least during, but not limited to, the pathogenic transmitting component thereof or pest component thereof, respectively.
  • the gene selected for RNAi targeting will be a gene that is normally active and involved in growth, differentiation renewal or reproduction of the insect vector or insect at least during, but not limited to, the phase of its life cycle that involves the transmission of a pathogenic organism or that which it acts as a pest, respectively.
  • an insect vector that transmits a pathogenic organism characterised in that; said insect comprises a genetically transformed or transfected bacterial cell wherein said bacteria is a gut symbiont of said insect and is transformed to express dsRNA against at least one selected target gene of the insect vector.
  • an insect that acts as a pest characterised in that; said insect comprises a genetically transformed or transfected bacterial cell wherein said bacteria is a gut symbiont of said insect and is transformed to express dsRNA against at least one selected target gene of the insect.
  • said insect vector or insect engages in horizontal gut flora transfer.
  • a target gene of an insect vector that transmits a pathogenic organism comprising:
  • said insect vector engages in horizontal gut flora transfer.
  • said composition comprises a food source for the insect vector. More preferably still, said composition is the faeces of said insect vector or insect, or a food source of the adult insect such as, but not limited to, a plant source or, in the case of haematophagous insects, a contaminated blood food source
  • modulating said target gene expression inhibits or reduces infectivity or pathogenicity of said insect vector, such as, but not limited to, its ability to transmit the pathogenic microorganism.
  • a target gene of an insect that acts as a pest comprising:
  • said insect engages in horizontal gut flora transfer.
  • said composition comprises a food source for the insect vector or insect. More preferably still, said composition is the faeces of said insect vector or insect, or a food source of the adult insect such as, but not limited to, a plant source or, in the case of haematophagous insects, a contaminated blood food source.
  • said method is applicable to investigate gene function in the insect, whereupon the function(s) of a particular gene can be determined as a consequence of its down-regulation, This therefore permits the identification of further gene targets for use in the control of pests or spread of pathogenic organisms.
  • modulating said target gene expression inhibits the activity of said insect, such as, but not limited to, its ability to feed, drink, colonise, or reproduce and in so doing reduces its impact as a pest.
  • any feature disclosed herein may be replaced by an alternative feature serving the same or a similar purpose.
  • FIG. 1 SEQID NO: 1 fragment A.
  • Nucleotide sequences 1 -6 and 367-373 are recognition sites for EcoRI; nucleotide sequence 7-102 is the sequence of the modified dapA promoter; nucleotide sequences 103-108 is a recognition site for Ndel; nucleotide sequence 109-348 is the 5' end of the dagA gene of Streptomyces coelicolor; nucleotide sequences 349-354 is a recognition site for Mlul; nucleotide sequences 355-360 is a recognition site for Nhel; nucleotide sequences 361 -366 is a recognition site for Sail.
  • SEQID NO:2 fragment B Nucleotide sequences 1 -6 and 121 -127 are recognition sites for EcoRI; nucleotide sequences 7-12 is a recognition site for Mlul; nucleotide sequences 13-18 is a recognition site for Ndel; nucleotide sequence 19- 1 13 is the sequence of the modified dapA promoter; nucleotide sequences 1 14-120 is a recognition site for Sail; nucleotide sequences 121 -126 is a recognition site for Nhel.
  • FIG. 3 SEQID NO:3 recombinant cassette in pMW101 .
  • Nucleotide sequences 1 - 6 and 463-468 are recognition sites for EcoRI;
  • nucleotide sequences 7-102 and 360- 456 are the sequences of the two copies of the convergent modified dapA promoter;
  • nucleotide sequences 103-108 and 355-360 are recognition sites for Ndel;
  • nucleotide sequence 109-348 is the 5' end of the dagA gene of Streptomyces coelicolor;
  • nucleotide sequences 349-354 is a recognition site for Mlul;
  • nucleotide sequences 457-462 is a recognition site for Sail.
  • Figure-4. SEQID NO: 15 RNaselll gene sequence. Rhodococcus rhodnii RNase III gene sequence (804 bp; internal Mlul site underlined).
  • FIG. 10 Vitellogenin gene fragment.
  • pLLMW1 1 insert sequence (vitellogenin sequence in upper case, Ndel sites in bold, underlined)
  • FIG. 7 SEQIDNO:1 1 nitrophorin-2 gene fragment.
  • pLLMW14 insert sequence nitrophorin-2 sequence in upper case, Ndel sites in bold, underlined.
  • FIG. 10 Example of R. prolixus salivary gland phenotypes following ingestion of R. rhodnii expressing dsRNA.
  • Control (dsAgarase) glands are cherry-red indicating normal synthesis of salivary nitrophorin proteins.
  • Knockdown of Nitrophorin-2 (dsNP2) results in colourless glands, and in extreme cases severe tissue wastage and crystallization of the luminal contents. Knockdown insects also exhibit aberrant / abortive feeding behaviours.
  • Rhodnius prolixus a large, long-lived blood-sucking bug, which has evolved a symbiotic relationship with Rhodococcus rhodnii bacteria essential for development of the insect.
  • R. prolixus is an important vector of Chagas disease due to transmission of trypanosomes during blood-feeds.
  • Newly-hatched insects are free from symbiotic bacteria and must acquire them through ingestion of R. rhodnii- contaminated faeces from other insects. This means that dsRNA expressing bacteria have the potential to spread naturally through a colony of insects by horizontal transfer.
  • This technique reduces insect handling and associated mortality, and is also cost-efficient.
  • This new technique forms the basis of a novel and highly specific pest control strategy that will target genes essential to insect survival, reproduction and transmission of parasites. It is particularly suited for application with insect vectors of tropical diseases, but is amenable to all invertebrates which have a gut suitable for uptake of dsRNA, and also a symbiotic gut bacteria amenable to genetic manipulation.
  • RNaselll an enzyme that specifically degrades dsRNA. Indeed we have established that dsRNA is unstable after it is expressed in R. rhodnius. To circumvent this problem, we have engineered a R. rhodnius mutant strain in which the gene encoding RNaselll is disrupted and which stably expresses dsRNA.
  • SEQID NO: 1 comprises a mutated copy of the promoter of the Cory nebacteri urn glutamicum dapA gene (coding for dihydrodipicolinate synthase).
  • this promoter sequence P-dapAMA16 differs from the wild-type dapA promoter in the sequence of the -10 hexamers (P-dapA - TAACCT; P-dapAMA16 - TATAAT), and has been demonstrated to have good activity in Rhodococcus erythropolis (Knoppova et al, 2007).
  • this promoter is fused to the 5' end 245 bp of the dagA gene of Streptomyces coelicolor. Expression of a double- stranded (ds) RNA copy of this sequence was designed to act as a negative control for subsequent experiments measuring knock-down effects in the insect Rhodnius prolixus.
  • Recognition sites for specific restriction enzymes (EcoRI, Nde ⁇ , Mlu ⁇ , Nhe ⁇ and Sa/I) were included at the ends and junctions of the promoter and dagA sequence to facilitate subsequent cloning steps ( Figure 1 ).
  • SEQID NO:2 comprises a second copy of P-dapAMA16 flanked by appropriate restriction sites (figure 2).
  • the two plasmids pCR2.1 -SEQID NO: 1 and pCR2.1 -SEQID NO:2 were cut with restriction enzymes Mlu ⁇ and Sa/I, the DNA's mixed and ligated with T4 DNA ligase. Following ligation, the DNA was further restricted with Nhe ⁇ to cut any of the original plasmids that had either been not cut to completion initially or had reformed by ligation.
  • coli strain JM109 (Yanisch-Perron et al., 1985) was electroporated and transformants selected by plating cells on L-agar containing ampicillin and kanamycin. Recombinant plasmids obtained this way were verified by restriction with EcoRI. One example was selected for further use, pMW101 containing the recombinant dsRNA expression cassette (SEQID NO:3; figure 3).
  • the plasmid pMW101 was first fused with plasmid plJ8600 (Sun et al, 1999) by cutting both with the restriction enzyme SamHI, ligating the two molecules with T4 DNA ligase, and recovering recombinant plasmids after electroporation of E. coli JM109 and plating cells on L-agar containing apramycin and kanamycin. Recombinant plasmids obtained this way were verified by restriction with EcoRV. One example was selected for further use and named pMW102.
  • this plasmid was cut with EcoRV, the DNA ligated and introduced by electroporation of E coli JM109, selecting cells on L-agar containing apramycin. Recombinant plasmids were verified by restriction with EcoRV.
  • pMW103 plJ8600 containing the expression cassette with dagA sequence.
  • R. prolixus genes encoding vitellogenin, nitrophorin-1 and nitrophorin-2 were obtained by PCR amplification using (respectively) primers RP1 1 (SEQID NO:4) & RP12 (SEQID NO:5), RP15 (SEQID NO:8) & RP16 (SEQID NO:9), and RP14 (SEQID NO: 6) & RP6 (SEQID NO:7).
  • GTTTCT overhangs were added to primers to improve priming efficiency, and Nde ⁇ sites added (with the exception of RP6, due to the presence of an Nde/ site in the immediate vicinity of the target sequence).
  • the chosen target sequences assessed as having a low risk of potential cross-silencing assessed as having a low risk of potential cross-silencing (Deqor online programme [ref: Henschel, A., et.al., Nucleic Acids Res. 2004 Jul 1 ;32(Web Server issue):W1 13-20] and ClustalW).
  • the amplicons were cloned into pGEM ⁇ -T Easy (Promega) and transformed into E. coli JM109. Following selection of positive clones by ampicillin resistance, and sequencing of the inserts of the correct size, each insert was then excised from pGEM ⁇ -T Easy by EcoRI restriction, and cloned into the E.
  • coli T7 expression vector pLL10 (Levashina et al 2001 ) by restriction of both vector and respective PCR product with EcoRI, calf intestinal phosphatase treatment of the vector, ligation of PCR product and vector with T4 DNA ligase, transformation of E coli JM109 and selection of recombinant colonies with ampicillin. Recombinant plasmids were verified by restriction with EcoRI and sequencing of those with inserts of the correct size.
  • Plasmids pMW104 (with the vitellogenin fragment), pMW105 (with the nitrophorin-2 fragment) and pMW106 (with the nitrophorin-1 fragment) were selected for further use.
  • RNase III deficient mutant of Rhodococcus rhodnii Degenerate primer RR4 (SEQID NO: 13) and primer RR5 (SEQID NO: 14) were designed from ClustalW alignments of RNase III gene sequences from related bacterial species, and used to amplify a 300 bp product from R. rhodnii, that was verified by sequencing as a fragment of RNase III. Sacl digests of wildtype R. rhodnii gDNA were then probed by Southern blotting using RR4 (SEQID NO: and RR5 labelled with digoxigenin (Roche PCR DIG Probe synthesis kit). The probes identified an approx.
  • the sequencing identified a Mlu ⁇ restriction site within the RNaselll coding sequence.
  • a kanamycin-resistance cassette flanked by Mlu ⁇ sites was generated by PCR.
  • the template for this was plasmid pME6 (Fernandez- Martinez et al, 2009), using as forward primer SEQID NO: 17, and as reverse primer SEQID NO: 18 (Mlu ⁇ sites underlined).
  • This amplicon was digested with Mlu ⁇ and ligated with pMW43 cut with MM
  • the recombinant plasmid was selected after electroporation of E. coli JM109 and growing on media containing both ampicillin and kanamycin.
  • pMW44 The plasmid pMW44 that was derived this way was verified by restriction analysis.
  • pMW44 was introduced into R. rhodnii by electroporation (see below for method), and recombinants selected by plating the bacteria on tryptic soy agar containing kanamycin.
  • Several recombinants were thus obtained and subsequently characterised by isolation of gGNA, restriction with Sacl and Southern hybridization with a probe consisting of the Sacl fragment containing the RNaselll gene isolated from pMW43. All kanamycin-resistant R. rhodnii clones possessed the disrupted RNaselll gene containing the kanamycin-resistant cassette.
  • the backbone of the expression cassette plasm ids (based on plJ8600) contains a site-specific recombination system, whereby after introduction of a plasm id by electroporation, the plasmid then integrates site-specifically into the R. rhodnius genome. Consequently, the expression cassette is maintained stably without recourse to constant antibiotic selection.
  • Aposymbiotic R. proiixus were raised from eggs sterilized for 10 minutes in iodine tincture (iodine 2.5% w/v, potassium iodide BP 2.5% w/v, ethanol 89% v/v) and rinsed twice with autoclaved water. [A 15 minute immersion in Savlon ⁇ solution followed by 3 washes is also effective].
  • the eggs were transferred to sterile plastic 25 ml tubes containing autoclaved filter paper and sealed with gas-permeable plate- sealer adhesive (Thermo Scientific), which formed a microbiological barrier.
  • Eggs and hatched insects were maintained in an incubator at 28°C, 70% RH with a 12: 12 light:dark cycle, and membrane-fed at intervals of 2-3 weeks with sterile defibrinated horse blood (TCS) in a sterile flow cabinet.
  • Non-sterile experimental insects were reared similarly, except the eggs were not sterilized and the insects were provided with soiled filter paper from the parental (non-sterile) insect colony, to ensure uptake of symbiotic bacteria by coprophagy.
  • blood in a Petri dish was heated to 37°C on a hot plate and covered with a sheet of sterile latex cut from Ansell Gammex® PF Micro-Thin® powder-free surgical glove.
  • the insect tubes' adhesive lids were replaced with autoclaved net fabric during feeding (to allow proboscis probing), fixed with a rubber band, and inverted over the feeding membrane.
  • Aposymbiotic and non-sterile insects of different ages were infected by membrane- feeding as above, by premixing transformed R. rhodnii with the blood.
  • the bacteria were cultured in TSB supplemented with apramycin, with shaking, at 28°C for 3 days, washed twice by centrifugation (and resuspension in sterile water, and mixed with horse blood to a concentration of 5x10 6 /ml. Unfed (unengorged) insects were easily identified and could thus be removed from the tubes following feeding.
  • insects were transferred to fresh containers under sterile conditions, and faeces in the vacated containers were assessed for the presence or absence of transformed bacteria and/or to verify sterile conditions. Tubes were rinsed with TSB, which was then spread on TSA plates +/- apramycin. Apramycin-resistant colonies were randomly sampled for the presence of cloned sequence by colony PCR using the relevant primers described above. Transformed bacteria were usually detectable in voided faeces within 48h of an infective feed. Gut contents from sacrificed insects were also monitored at regular timepoints post infective feeding.
  • FIG 10 shows an example of R. prolixus salivary gland phenotypes following ingestion of R. rhodnii expressing dsRNA against nitrophorin 2 (test) or agarase (control).
  • Control dsAgarase
  • Control dsAgarase
  • Knockdown of Nitrophorin-2 (dsNP2) results in colourless glands, and in extreme cases severe tissue wastage and crystallization of the luminal contents. Knockdown insects also exhibit aberrant / abortive feeding behaviours. This experiment thus demonstrates the effectiveness of the technology for targeting specific genes and so interfering with the insect host phenotype in a manner deleterious to feeding and so survival.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pest Control & Pesticides (AREA)
  • Virology (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Cell Biology (AREA)
  • Insects & Arthropods (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

La présente invention concerne une cellule bactérienne génétiquement transformée ou transfectée, ladite bactérie étant un symbiote intestinale d'un insecte vecteur ou d'un insecte nuisible ; caractérisée en ce que ladite cellule bactérienne est transformée pour exprimer un dsRNA contre au moins un gène cible sélectionné de l'insecte vecteur, moyennant quoi l'effet ou la viabilité dudit insecte est compromise de manière délétère ; également un insecte comprenant ladite cellule bactérienne et un procédé de modulation d'un gène cible d'insecte à l'aide de ladite cellule bactérienne.
PCT/GB2013/050228 2012-02-08 2013-02-01 Lutte contre les pathogènes et nuisibles WO2013117910A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB1415502.2A GB2513811A (en) 2012-02-08 2013-02-01 Pest And Pathogen Control

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1202119.2 2012-02-08
GBGB1202119.2A GB201202119D0 (en) 2012-02-08 2012-02-08 Pest and pathogen control

Publications (1)

Publication Number Publication Date
WO2013117910A1 true WO2013117910A1 (fr) 2013-08-15

Family

ID=45896761

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2013/050228 WO2013117910A1 (fr) 2012-02-08 2013-02-01 Lutte contre les pathogènes et nuisibles

Country Status (2)

Country Link
GB (2) GB201202119D0 (fr)
WO (1) WO2013117910A1 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015042556A1 (fr) * 2013-09-23 2015-03-26 Georgia Tech Research Corporation Ciblage d'arn non codant pour interférence arn
WO2016198852A1 (fr) * 2015-06-11 2016-12-15 Swansea University Système de lutte contre les insectes nuisibles
WO2017160600A1 (fr) * 2016-03-15 2017-09-21 Apse, Inc Procédés et compositions destinés à la production d'arn à double brin accrue
WO2018053451A1 (fr) * 2016-09-16 2018-03-22 Pebble Labs Nouveau système paratransgénique pour la lutte biologique contre les moustiques transmetteurs de maladies
CN111148434A (zh) * 2017-01-24 2020-05-12 旗舰创业创新五公司 用于制造食物和饲料的方法和相关组合物
US11015199B2 (en) 2015-11-09 2021-05-25 Swansea University Cancer therapy

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005110068A2 (fr) * 2004-04-09 2005-11-24 Monsanto Technology Llc Compositions et procédés pour le contrôle des invasions d'insectes sur les plantes
WO2011017137A2 (fr) 2009-08-03 2011-02-10 Alnylam Pharmaceuticals, Inc. Procédés et compositions de traitement d'insectes
WO2011025860A1 (fr) 2009-08-28 2011-03-03 E. I. Du Pont De Nemours And Company Compositions et procédés de lutte contre les insectes nuisibles
WO2011036536A2 (fr) 2009-09-25 2011-03-31 Arterra Bioscience S.R.L. Micro-organismes inactivés contenant des molécules d'arn double brin (dsarn), leur utilisation comme pesticides et leurs procédés de préparation
EP2374462A2 (fr) 2006-01-12 2011-10-12 deVGen N.V. Procédés de contrôle de nuisibles au moyen d'ARNi

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005110068A2 (fr) * 2004-04-09 2005-11-24 Monsanto Technology Llc Compositions et procédés pour le contrôle des invasions d'insectes sur les plantes
EP2374462A2 (fr) 2006-01-12 2011-10-12 deVGen N.V. Procédés de contrôle de nuisibles au moyen d'ARNi
WO2011017137A2 (fr) 2009-08-03 2011-02-10 Alnylam Pharmaceuticals, Inc. Procédés et compositions de traitement d'insectes
WO2011025860A1 (fr) 2009-08-28 2011-03-03 E. I. Du Pont De Nemours And Company Compositions et procédés de lutte contre les insectes nuisibles
WO2011036536A2 (fr) 2009-09-25 2011-03-31 Arterra Bioscience S.R.L. Micro-organismes inactivés contenant des molécules d'arn double brin (dsarn), leur utilisation comme pesticides et leurs procédés de préparation

Non-Patent Citations (15)

* Cited by examiner, † Cited by third party
Title
ARAUJO R N ET AL: "RNA interference of the salivary gland nitrophorin 2 in the triatomine bug Rhodnius prolixus (Hemiptera: Reduviidae) by dsRNA ingestion or injection", INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY, ELSEVIER SCIENCE LTD, GB, vol. 36, no. 9, 13 June 2006 (2006-06-13), pages 683 - 693, XP025014546, ISSN: 0965-1748, [retrieved on 20060901], DOI: 10.1016/J.IBMB.2006.05.012 *
COUTINHO-ABREU I V ET AL: "Transgenesis and paratransgenesis to control insect-borne diseases: Current status and future challenges", PARASITOLOGY INTERNATIONAL, ELSEVIER SCIENCE, AMSTERDAM, NL, vol. 59, no. 1, 9 October 2009 (2009-10-09), pages 1 - 8, XP026906417, ISSN: 1383-5769, [retrieved on 20091009], DOI: 10.1016/J.PARINT.2009.10.002 *
ELLEN M DOTSON ET AL: "Transformation of Rhodococcus rhodnii, a symbiont of the Chagas disease vector Rhodnius prolixus, with integrative elements of the L1 mycobacteriophage", INFECTION, GENETICS AND EVOLUTION, vol. 3, no. 2, 24 January 2003 (2003-01-24), pages 103 - 109, XP055061120, ISSN: 1567-1348, DOI: 10.1016/S1567-1348(03)00002-9 *
FERNANDEZ MARTINEZ ET AL.: "Osmoregulation in Streptomyces coelicolor: modulation of SigB activity by OsaC", MOL MICROBIO, vol. 71, 2009, pages 1250 - 1262
HE LIN ET AL: "PcnB is required for the rapid degradation of RNAI, the antisense RNA that controls the copy number of ColE1-related plasmids", MOLECULAR MICROBIOLOGY, WILEY-BLACKWELL PUBLISHING LTD, GB, vol. 9, no. 6, 1 January 1993 (1993-01-01), pages 1131 - 1142, XP002568715, ISSN: 0950-382X, DOI: 10.1111/J.1365-2958.1993.TB01243.X *
HENSCHEL ET AL.: "DEQOR: a web-based tool for the design and quality control of siRNAs", NUCLEIC ACIDS RES., vol. 32, 2004, pages 113 - 20
HENSCHEL, A., NUCLEIC ACIDS RES., vol. 32, 1 July 2004 (2004-07-01), pages 113 - 20
HUVENNE H ET AL: "Mechanisms of dsRNA uptake in insects and potential of RNAi for pest control: A review", JOURNAL OF INSECT PHYSIOLOGY, PERGAMON PRESS, OXFORD, GB, vol. 56, no. 3, 9 October 2009 (2009-10-09), pages 227 - 235, XP026889277, ISSN: 0022-1910, [retrieved on 20091027], DOI: 10.1016/J.JINSPHYS.2009.10.004 *
HUVENNE; SMAGGHE: "Mechanisms of dsRNA uptake in insects and potential of RNAi for pest control: a review", J INSECT PHYSIOL, vol. 56, no. 3, 2010, pages 227 - 35, XP026889277, DOI: doi:10.1016/j.jinsphys.2009.10.004
IVY HURWITZ ET AL: "Paratransgenic control of vector borne diseases", INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, vol. 7, no. 9, 1 November 2011 (2011-11-01), pages 1334 - 1344, XP055061147, ISSN: 1449-2288 *
KNOPPOVA ET AL.: "Plasmid vectors for testing in vivo promoter activities in Corynebacterium glutamicum and Rhodococcus erythropolis", CURR MICROBIOL., vol. 55, 2007, pages 234 - 9, XP019539741, DOI: doi:10.1007/s00284-007-0106-1
MARTIN K. RONO ET AL: "The Major Yolk Protein Vitellogenin Interferes with the Anti-Plasmodium Response in the Malaria Mosquito Anopheles gambiae", PLOS BIOLOGY, vol. 8, no. 7, 20 July 2010 (2010-07-20), pages e1000434, XP055060714, ISSN: 1544-9173, DOI: 10.1371/journal.pbio.1000434 *
R. V. DURVASULA ET AL: "Prevention of insect-borne disease: An approach using transgenic symbiotic bacteria", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 94, no. 7, 1 April 1997 (1997-04-01), pages 3274 - 3278, XP055061209, ISSN: 0027-8424, DOI: 10.1073/pnas.94.7.3274 *
SUN ET AL.: "Green fluorescent protein as a reporter for spatial and temporal gene expression in Streptomyces coelicolor A3(2", MICROBIOLOGY, vol. 145, 1999, pages 2221 - 2227, XP001030821
YANISCH-PERRON ET AL.: "Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors", GENE, vol. 33, 1985, pages 103 - 119, XP023541292, DOI: doi:10.1016/0378-1119(85)90120-9

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10329560B2 (en) 2013-09-23 2019-06-25 Georgia Tech Research Corporation Targeting non-coding RNA for RNA interference
WO2015042556A1 (fr) * 2013-09-23 2015-03-26 Georgia Tech Research Corporation Ciblage d'arn non codant pour interférence arn
WO2016198852A1 (fr) * 2015-06-11 2016-12-15 Swansea University Système de lutte contre les insectes nuisibles
US11015199B2 (en) 2015-11-09 2021-05-25 Swansea University Cancer therapy
CN109196102A (zh) * 2016-03-15 2019-01-11 阿普斯公司 增加双链rna产生的方法和组合物
US10704045B2 (en) 2016-03-15 2020-07-07 Apse, Inc. Methods and compositions for increased double stranded RNA production
WO2017160600A1 (fr) * 2016-03-15 2017-09-21 Apse, Inc Procédés et compositions destinés à la production d'arn à double brin accrue
CN109196102B (zh) * 2016-03-15 2022-04-26 阿普斯公司 增加双链rna产生的方法和组合物
US11718851B2 (en) 2016-03-15 2023-08-08 Rnaissance Ag Llc Methods and compositions for increased double stranded RNA production
US10294475B2 (en) 2016-09-16 2019-05-21 Pebble Labs, Inc. Paratransgenic system for the biocontrol of disease-transmitting mosquitos
WO2018053451A1 (fr) * 2016-09-16 2018-03-22 Pebble Labs Nouveau système paratransgénique pour la lutte biologique contre les moustiques transmetteurs de maladies
US11396653B2 (en) 2016-09-16 2022-07-26 Pebble Labs Inc. System for the biocontrol of disease-transmitting mosquitoes and their eggs using horizontally transferable symbiotic bacteria to deliver pathogen specific interfering RNA polynucleotides
CN111148434A (zh) * 2017-01-24 2020-05-12 旗舰创业创新五公司 用于制造食物和饲料的方法和相关组合物
CN111148434B (zh) * 2017-01-24 2023-11-17 旗舰创业创新五公司 用于制造食物和饲料的方法和相关组合物

Also Published As

Publication number Publication date
GB201202119D0 (en) 2012-03-21
GB2513811A (en) 2014-11-05
GB201415502D0 (en) 2014-10-15

Similar Documents

Publication Publication Date Title
US11117938B2 (en) RNA interference for control of insect pests
JP2019150036A (ja) Ｒｎａの生成及び送達のための組成物及び方法
WO2013117910A1 (fr) Lutte contre les pathogènes et nuisibles
JP2016517274A5 (fr)
US11344009B2 (en) All sterile males of culicine mosquitoes: a method of creation
Hunter et al. Emerging RNA suppression technologies to protect citrus trees from citrus greening disease bacteria
Hunter et al. BAPC-assisted CRISPR/Cas9 system: targeted delivery into adult ovaries for heritable germline gene editing (Arthropoda: Hemiptera)
US20190276830A1 (en) Novel Paratransgenic System for the Biocontrol of Disease-Transmitting Mosquitos
EP3307914B1 (fr) Système de lutte contre les insectes nuisibles
WO2022204466A1 (fr) Production de polyribonucléotides circulaires dans un système procaryote
WO2019237919A1 (fr) Polynucléotide et procédé pour lutter contre une infestation par des insectes
Su et al. Rational engineering of a synthetic insect-bacterial mutualism
Mahmood et al. Current knowledge and implementations of Bemisia tabaci genomic technologies for sustainable control
US20230371483A1 (en) Methods and compositions for sexing and sterilization in drosophila suzukii and aedes aegypti
CN107603984B (zh) 用于控制昆虫侵袭的核苷酸序列及其方法
Ai et al. Transgenic tobacco expressing dsRNA of the arginine kinase gene exhibits enhanced resistance against Helicoverpa armigera.
Kumara et al. Advances, Prospects and Limitations of Genetic Tools for Pest Management Strategies in Sri Lanka
WO2021242782A1 (fr) Technique pour insecte stérile guidée avec précision inductible par un locus ou technique pour insecte stérile guidée avec précision inductible par température
RU2775717C1 (ru) Полинуклеотид и способ, используемый для осуществления контроля над нашествием насекомых
Lin et al. Development of a RNAi-based release of insects carrying a dominant lethal (RIDL) system in Drosophila melanogaster
RU2775943C1 (ru) Полинуклеотид и способ для осуществления контроля над поражением насекомыми
RU2781829C2 (ru) Полинуклеотид и способ борьбы с нашествием насекомых
Ai XinYu et al. Transgenic tobacco expressing dsRNA of the arginine kinase gene exhibits enhanced resistance against Helicoverpa armigera.
De Schutter et al. RNA interference to modify phenotypes in agriculturally important pest and beneficial insects: useful examples and future challenges.
US20220248690A1 (en) Sex-linked rnai insecticide materials and methods

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13705230

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 1415502

Country of ref document: GB

Kind code of ref document: A

Free format text: PCT FILING DATE = 20130201

WWE Wipo information: entry into national phase

Ref document number: 1415502.2

Country of ref document: GB

122 Ep: pct application non-entry in european phase

Ref document number: 13705230

Country of ref document: EP

Kind code of ref document: A1